pre-IPO PHARMA

COMPANY OVERVIEW

Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest diseases.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Cardiovascular Disease
  • Neurodegenerative Disease
  • Oncology
  • Women's Health

  • WEBSITE

    https://www.dewpointtherapeutics.com


    CAREER WEBSITE

    https://www.dewpointtherapeutics.com/careers


    SOCIAL MEDIA


    INVESTORS

    6-dimensions-captial alexandria-venture-investments ecor1-capital leaps-by-bayer polaris-partners samsara-biocapital


    PRESS RELEASES


    Nov 14, 2022

    Dewpoint Therapeutics Granted Second Breakthrough Condensates Platform Technology Patent by US Patent Office


    Dec 20, 2021

    Palantir and Dewpoint Therapeutics Announce Strategic Partnership


    Dec 20, 2021

    Palantir and Dewpoint Therapeutics Announce Strategic Partnership


    Sep 28, 2021

    Dewpoint Therapeutics Appoints Lori Escobedo as Chief People Officer


    Jul 13, 2020

    Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV


    For More Press Releases


    Google Analytics Alternative